Novel formulation delivers synergistic effect for treatment of Otitis externa in dogs
DESCRIPTION:
Surolan contains Miconazole, Polymyxin B and Prednisolone in combination to address the majority of pathogens that cause Otitis externa as well as treat associated inflammation. In this unique formulation, the combination of Miconazole and Polymyxin B delivers a synergistic effect greater than either product alone, making Surolan the first choice for both new and bounce back cases. Additionally, Surolan's unique formulation provides a topical antifungal/antibacterial option different from those used systemically, which may help minimize potential resistance issues.
- 96.7% of pets show clinical improvement within 7 days
- Proven safety profile
- No known interaction with other medications
- FDA-approved
- Available only from licensed veterinarians
METHOD OF ACTION:
Your best choice for first line treatment of Otitis externa.
- Broad-spectrum activity
- Dual antimicrobial action
- Reduced risk of resistance
- Mild anti-inflammatory
FORMULATION(S):
Formulated for easy administration and compliance:
- Liquid formulation travels easily to where pathogens reside
- Dropper included for precise dosing
- Requires no refrigeration, adding to pet comfort and acceptance
- Proven to be well tolerated
- Non-greasy, non-staining
- Available in 2 convenient sizes: 15 mL and 30 mL
DOSING AND TREATMENT:
Shake well before use. Instill 5 drops of Surolan in the ear canal twice daily and gently massage the ear. Continue treatment for 7 consecutive days.
Refer to Surolan Brochure for chart references.
Surolan Brochure (pdf)
-
References:
- Cornelissen F, et al. Synergism of the antimicrobial agents of Miconazole, Bacitracin and Polymyxin B. Chemoth 1983;29:419-27.
- NADA #141-298, Janssen Pharmaceutica NV, Beerse, Belgium; 2009.
